Psoriasis Treatment Center Of Central New Jersey

This study looked at whether tralokinumab could help adults with moderate-to-severe eczema who had not improved enough with dupilumab. Only 7 people took part before the study was stopped early. Participants received tralokinumab injections every two weeks for 24 weeks, and the m…

This study tested the drug upadacitinib in adults with moderate-to-severe prurigo nodularis, a condition causing very itchy skin bumps. The goal was to see if it could reduce itching over 24 weeks. Only 5 people took part before the study was stopped early, so results are limited…